AngioDynamics, Inc. (ANGO) - Product Pipeline Analysis, 2016 Update

Date: September 14, 2016
Pages: 72
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AECE0E8650BEN
Leaflet:

Download PDF Leaflet

AngioDynamics, Inc. (ANGO) - Product Pipeline Analysis, 2016 Update
Summary

AngioDynamics, Inc. (AngioDynamics) is a provider of medical, surgical and diagnostic devices. Its major products include peripheral vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis and embolization, besides venous products and renal therapy products. The company’s products are used by interventional radiologists, interventional cardiologists, surgeons and physicians for the minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease. The company sells its products through direct sales force in the US and through a network of distributors outside the US. The company has operations in North America, Europe and Asia. AngioDynamics is headquartered in New York, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company AngioDynamics, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
AngioDynamics, Inc. Company Overview
AngioDynamics, Inc. Company Snapshot
AngioDynamics, Inc. Pipeline Products and Clinical Trials Overview
AngioDynamics, Inc. – Pipeline Analysis Overview
Business Description
Key Facts
AngioDynamics, Inc. - Major Products and Services
AngioDynamics, Inc. Pipeline Products by Development Stage
AngioDynamics, Inc. Clinical Trials by Trial Status
AngioDynamics, Inc. Pipeline Products Overview
AngioVac Line Extension
AngioVac Line Extension Product Overview
AngioVac Low Profile Catheter
AngioVac Low Profile Catheter Product Overview
Automated Fluid Management System
Automated Fluid Management System Product Overview
BioFlo PICC Line Extension
BioFlo PICC Line Extension Product Overview
BioFlo Portline Line Extension
BioFlo Portline Line Extension Product Overview
Celerity PICC Tip Confirmation System With Navigation
Celerity PICC Tip Confirmation System With Navigation Product Overview
Coronary Angio Catheter
Coronary Angio Catheter Product Overview
Drainage Line Extension
Drainage Line Extension Product Overview
FireFly Tip Location
FireFly Tip Location Product Overview
Inflation Device
Inflation Device Product Overview
Mechanical Thrombectomy Device
Mechanical Thrombectomy Device Product Overview
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma Product Overview
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma Clinical Trial
NanoKnife System - Pancreatic Cancer
NanoKnife System - Pancreatic Cancer Product Overview
NanoKnife System - Pancreatic Cancer Clinical Trial
NanoKnife System - Prostate Cancer
NanoKnife System - Prostate Cancer Product Overview
NanoKnife System - Prostate Cancer Clinical Trial
Next Gen Tumescent Delivery Device
Next Gen Tumescent Delivery Device Product Overview
Next Generation BioFlo PICC
Next Generation BioFlo PICC Product Overview
Next Generation BioFlo Port
Next Generation BioFlo Port Product Overview
Next Generation Dialysis Device
Next Generation Dialysis Device Product Overview
Next Generation Laser
Next Generation Laser Product Overview
Next Generation Microwave Ablation
Next Generation Microwave Ablation Product Overview
Next Generation NanoKnife Device
Next Generation NanoKnife Device Product Overview
Next Generation NanoKnife Device Clinical Trial
Next Generation Radio Frequency Ablation System
Next Generation Radio Frequency Ablation System Product Overview
Non-Thermal Vein Ablation Device
Non-Thermal Vein Ablation Device Product Overview
Non-Vascular Introducer
Non-Vascular Introducer Product Overview
Power Injectable Port
Power Injectable Port Product Overview
Smart Port - Dual
Smart Port - Dual Product Overview
Thrombus Management Device
Thrombus Management Device Product Overview
Ultrasound-Assisted Thrombectomy System
Ultrasound-Assisted Thrombectomy System Product Overview
AngioDynamics, Inc. - Key Competitors
AngioDynamics, Inc. - Key Employees
AngioDynamics, Inc. - Key Employee Biographies
AngioDynamics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
AngioDynamics, Inc., Recent Developments
Jul 27, 2016: AngioDynamics Issues Statement Regarding Stryker recall of Angiographic Catheters
Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer
Jul 22, 2016: Angiodynamics Soft Vu Omni Flush Angiographic Catheter by Stryker Sustainability Solutions (formerly Ascent Healthcare Solutions): Class I Recall - Tip Separation
Jul 14, 2016: ‘Healthy Tech’ on Display at Advocate Sherman Hospital
Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results
May 13, 2016: Joint exhibition with Angiodynamics at the German Radiology Congress
Apr 07, 2016: AngioDynamics Reports Fiscal 2016 Third Quarter Results
Apr 04, 2016: AngioDynamics Appoints James C. Clemmer as New President and Chief Executive Officer
Feb 08, 2016: AngioDynamics Announces the Approval of the Celerity PICC Tip Confirmation System With Navigation in Canada
Jan 07, 2016: AngioDynamics Reports Fiscal 2016 Second Quarter Results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

AngioDynamics, Inc. Pipeline Products and Clinical Trials Overview
AngioDynamics, Inc. Pipeline Products by Equipment Type
AngioDynamics, Inc. Pipeline Products by Indication
AngioDynamics, Inc. Clinical Trials by Trial Status
AngioDynamics, Inc., Key Facts
AngioDynamics, Inc., Major Products and Services
AngioDynamics, Inc. Number of Pipeline Products by Development Stage
AngioDynamics, Inc. Pipeline Products Summary by Development Stage
AngioDynamics, Inc. Clinical Trials by Trial Status
AngioDynamics, Inc. Clinical Trials Summary
AngioVac Line Extension - Product Status
AngioVac Line Extension - Product Description
AngioVac Low Profile Catheter - Product Status
AngioVac Low Profile Catheter - Product Description
Automated Fluid Management System - Product Status
Automated Fluid Management System - Product Description
BioFlo PICC Line Extension - Product Status
BioFlo PICC Line Extension - Product Description
BioFlo Portline Line Extension - Product Status
BioFlo Portline Line Extension - Product Description
Celerity PICC Tip Confirmation System With Navigation - Product Status
Celerity PICC Tip Confirmation System With Navigation - Product Description
Coronary Angio Catheter - Product Status
Coronary Angio Catheter - Product Description
Drainage Line Extension - Product Status
Drainage Line Extension - Product Description
FireFly Tip Location - Product Status
FireFly Tip Location - Product Description
Inflation Device - Product Status
Inflation Device - Product Description
Mechanical Thrombectomy Device - Product Status
Mechanical Thrombectomy Device - Product Description
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Product Status
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Product Description
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - A Prospective Clinical Trial Using Irreversible Electroporation (IRE) for the Treatment of Unresectable Hepatic Carcinoma Close to the Gallbladder
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - A Prospective Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Colorectal Metastatic Liver Disease: Efficacy of Irreversible Electroporation (IRE) - A Phase II Clinical Trial (COLDFIRE-2 Study)
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Comparison Percutaneous Cryosurgery and Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Hepatic Carcinoma in Poor Liver Function: Safety and Efficacy of Irreversible Electroporation (IRE)
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Irreversible Electroporation (IRE) for Unresectable Portal Venous Tumor Emboli: Phase I and Phase II Clinical Trial
NanoKnife System - Pancreatic Cancer - Product Status
NanoKnife System - Pancreatic Cancer - Product Description
NanoKnife System - Pancreatic Cancer - A Clinical Research about Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer
NanoKnife System - Pancreatic Cancer - Evaluation of the Short and Intermediate Term Outcomes of Ablation of Locally Advanced Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System - A Prospective Study
NanoKnife System - Pancreatic Cancer - IRE: Anti-tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer
NanoKnife System - Pancreatic Cancer - Pilot-study: Non-thermal Ablation Using Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma - A Phase I Clinical Trial - PANFIRE
NanoKnife System - Prostate Cancer - Product Status
NanoKnife System - Prostate Cancer - Product Description
NanoKnife System - Prostate Cancer - A Prospective Development Study Evaluating Focal Therapy Using Irreversible Electroporation (Nanoknife) in Men with Localised Prostate Cancer
NanoKnife System - Prostate Cancer - Irreversible Electroporation(IRE) for Unresectable Prostatic Neoplasms: Phase I and Phase II Clinical Trial
NanoKnife System - Prostate Cancer - Multi-center Randomized Clinical Two Arm Intervention Study Evaluating Irreversible Electroporation for the Ablation of Localized Prostate Cancer
Next Gen Tumescent Delivery Device - Product Status
Next Gen Tumescent Delivery Device - Product Description
Next Generation BioFlo PICC - Product Status
Next Generation BioFlo PICC - Product Description
Next Generation BioFlo Port - Product Status
Next Generation BioFlo Port - Product Description
Next Generation Dialysis Device - Product Status
Next Generation Dialysis Device - Product Description
Next Generation Laser - Product Status
Next Generation Laser - Product Description
Next Generation Microwave Ablation - Product Status
Next Generation Microwave Ablation - Product Description
Next Generation NanoKnife Device - Product Status
Next Generation NanoKnife Device - Product Description
Next Generation NanoKnife Device - The Safety and Feasibility of Irreversible Electroporation for the Ablation of Small Renal Masses
Next Generation Radio Frequency Ablation System - Product Status
Next Generation Radio Frequency Ablation System - Product Description
Non-Thermal Vein Ablation Device - Product Status
Non-Thermal Vein Ablation Device - Product Description
Non-Vascular Introducer - Product Status
Non-Vascular Introducer - Product Description
Power Injectable Port - Product Status
Power Injectable Port - Product Description
Smart Port - Dual - Product Status
Smart Port - Dual - Product Description
Thrombus Management Device - Product Status
Thrombus Management Device - Product Description
Ultrasound-Assisted Thrombectomy System - Product Status
Ultrasound-Assisted Thrombectomy System - Product Description
AngioDynamics, Inc., Key Employees
AngioDynamics, Inc., Key Employee Biographies
AngioDynamics, Inc., Other Locations
AngioDynamics, Inc., Subsidiaries

LIST OF FIGURES

AngioDynamics, Inc. Pipeline Products by Equipment Type
AngioDynamics, Inc. Pipeline Products by Development Stage
AngioDynamics, Inc. Clinical Trials by Trial Status
Skip to top


Ask Your Question

AngioDynamics, Inc. (ANGO) - Product Pipeline Analysis, 2016 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: